About Stratos Genomics Inc.
Stratos Genomics' goal is to establish the next gold standard of DNA sequencing with its flagship 'Sequencing by Expansion' (SBX™) method. SBX is a simple, elegant, single-molecule detection process that circumvents the limitations of competing technologies, allowing accurate, ultra-low-cost whole genome sequencing.
Recent News
August.23.11
“The additional funding will allow us to expand our development efforts and bring us one step closer to realizing the enormous potential of our Sequencing by Expansion™ technology.” Mark Kokoris, Chief Science Officer, Stratos Genomics said.
June.08.11
Stratos Genomics Announces Financing for Validation of SBX™ Genome Sequencing Technology
“We are fortunate to have great results and supportive investors. Our shareholders recognize that we are entering an exciting phase and don’t want our validation pace interrupted by external fundraising activities,” CEO Allan Stephan said.
May.25.11
Stratos Genomics Receives Fundamental Patent on Sequencing by Expansion™ Technology
Sequencing by Expansion enables ultra-low-cost sequencing on a range of affordable measurement technologies for servicing a full spectrum of genomic applications.